Two new studies show that a new drug called Cimzia may ease symptoms of Crohn’s disease.
Cimzia hasn’t been approved by the FDA yet. Patients would give themselves injections of the drug, which targets an inflammatory chemical called tumor necrosis factor (TNF) alpha.
The two new studies, published in The New England Journal of Medicine, highlight Cimzia’s clinical trials in Crohn’s disease patients.
Read rest of this article at WebMD site.
Biosingularity 